BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Levin A, Shibolet O. Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory. World J Gastroenterol 2008; 14(33): 5149-5153 [PMID: 18777591 DOI: 10.3748/wjg.14.5149]
URL: https://www.wjgnet.com/1007-9327/full/v14/i33/5149.htm
Number Citing Articles
1
Wei Dou, Jingjing Zhang, Aning Sun, Eryun Zhang, Lili Ding, Subhajit Mukherjee, Xiaohui Wei, Guixin Chou, Zheng-Tao Wang, Sridhar Mani. Protective effect of naringenin against experimental colitis via suppression of Toll-like receptor 4/NF-κB signallingBritish Journal of Nutrition 2013; 110(4): 599 doi: 10.1017/S0007114512005594
2
Bor-Chyuan Su, Jyh-Yih Chen. Antimicrobial Peptide Epinecidin-1 Modulates MyD88 Protein Levels via the Proteasome Degradation PathwayMarine Drugs 2017; 15(11): 362 doi: 10.3390/md15110362
3
C. Lutz, B. Weder, A. Hünerwadel, S. Fagagnini, B. Lang, N. Beerenwinkel, J. B. Rossel, G. Rogler, B. Misselwitz, M. Hausmann. Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis developmentScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17755-7
4
Hubert Hug, M. Mohajeri, Giorgio La Fata. Toll-Like Receptors: Regulators of the Immune Response in the Human GutNutrients 2018; 10(2): 203 doi: 10.3390/nu10020203
5
Bin Zheng, Mary E. Morgan, Hendrik J.G. van de Kant, Johan Garssen, Gert Folkerts, Aletta D. Kraneveld. Transcriptional modulation of pattern recognition receptors in chronic colitis in mice is accompanied with Th1 and Th17 responseBiochemistry and Biophysics Reports 2017; 12: 29 doi: 10.1016/j.bbrep.2017.08.009
6
Wei-Lian Bao, Qibiao Wu, Bin Hu, Dongdong Sun, Shengnan Zhao, Xiaoyan Shen, Haibo Cheng, Weixing Shen. Oral Nanoparticles of SNX10-shRNA Plasmids Ameliorate Mouse ColitisInternational Journal of Nanomedicine 2021; : 345 doi: 10.2147/IJN.S286392
7
Fabio Alessandro Facchini, Davide Di Fusco, Simona Barresi, Andrea Luraghi, Alberto Minotti, Francesca Granucci, Giovanni Monteleone, Francesco Peri, Ivan Monteleone. Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitisEuropean Journal of Clinical Pharmacology 2020; 76(3): 409 doi: 10.1007/s00228-019-02799-7
8
I. J. J. Claes, Sarah Lebeer, C. Shen, T. L. A. Verhoeven, E. Dilissen, G. De Hertogh, D. M. A. Bullens, J. L. Ceuppens, G. Van Assche, S. Vermeire, P. Rutgeerts, J. Vanderleyden, S. C. J. De Keersmaecker. Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitisClinical & Experimental Immunology 2010; 162(2): 306 doi: 10.1111/j.1365-2249.2010.04228.x
9
Alex I. Chernyavsky, Valentin Galitovskiy, Igor B. Shchepotin, Sergei A. Grando. Anti-Inflammatory Effects of the Nicotinergic Peptides SLURP-1 and SLURP-2 on Human Intestinal Epithelial Cells and ImmunocytesBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/609086
10
ShuMin Sun, XueLin Wang, XiuPing Wu, Ying Zhao, Feng Wang, XiaoLei Liu, YanXia Song, ZhiLiang Wu, MingYuan Liu. Toll-like receptor activation by helminths or helminth products to alleviate inflammatory bowel diseaseParasites & Vectors 2011; 4(1) doi: 10.1186/1756-3305-4-186
11
Adriano Lama, Gustavo Provensi, Roberta Amoriello, Claudio Pirozzi, Barbara Rani, Maria Pina Mollica, Giuseppina Mattace Raso, Clara Ballerini, Rosaria Meli, Maria Beatrice Passani. The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in miceBiomedicine & Pharmacotherapy 2020; 129: 110368 doi: 10.1016/j.biopha.2020.110368
12
C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hörmannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller, D. Kelly. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel diseaseInflammatory Bowel Diseases 2009; 15(11): 1721 doi: 10.1002/ibd.20999
13
Hyesun Hyun, Seika Hashimoto-Hill, Myunghoo Kim, Michael D. Tsifansky, Chang H. Kim, Yoon Yeo. Succinylated Chitosan Derivative Has Local Protective Effects on Intestinal InflammationACS Biomaterials Science & Engineering 2017; 3(8): 1853 doi: 10.1021/acsbiomaterials.7b00262